Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Metropolis Healthcare
METROPOLIS
Metropolis Healthcare
Digital Testing Will Undermine Traditional Diagnostics Profitability
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
22 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
₹1,655.00
31.1% overvalued
intrinsic discount
21 Aug
₹2,169.50
Loading
1Y
5.0%
7D
2.3%
Author's Valuation
₹1.7k
31.1% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
₹1.7k
31.1% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
20b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue ₹19.8b
Earnings ₹2.9b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
12.55%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹2.88b
Earnings '28
x
43.64x
PE Ratio '28
=
₹125.65b
Market Cap '28
₹125.65b
Market Cap '28
/
53.52m
No. shares '28
=
₹2.35k
Share Price '28
₹2.35k
Share Price '28
Discounted to 2025 @ 12.73% p.a.
=
₹1.64k
Fair Value '25